EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

By A. Heidenreich, P. Bastian, J. Bellmunt, Michel Bolla, Steven Joniau, T. Kwast, M. Mason, V. Matveev, Thomas Wiegel, F. Zattoni and 1 more. European Urology, 2014

2,039 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Urology

View Paper: https://www.semanticscholar.org/paper/e129068a8f79916035d05aea43aaf1bd48d0b3e1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. Michel Bolla
2. N. Mottet
3. J. Bellmunt
4. V. Matveev
5. Steven Joniau
6. Thomas Wiegel

Citations in the corpus

• EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. (2015, background): “PSA and PCa probability The role of serum PSA in the diagnosis of PCa is described in the EAU guidelines on prostate cancer [49].”
• EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2017, background): “The most recent summary of the European Association of Urology (EAU) [8_TD$DIFF]Guidelines on prostate cancer (PCa) was published in 2013 [1].”
• Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study. (2019, background): “International guidelines recommend systematic 12-core transrectal ultrasound-guided biopsy (TRUSGB) in biopsynaïve men with elevated prostate-specific antigen (PSA) serum levels of >3 ng/ml [1,2].”